Non-small cell lung cancer: Clinical value of new biological predictors

被引：61

作者：

Graziano, SL ^{[1
]}

机构：

[1] SUNY HLTH SCI CTR, SYRACUSE, NY 13210 USA

来源：

关键词：

lung cancer; non-small cell lung cancer; prognosis;

D O I：

10.1016/S0169-5002(97)00639-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S37 / S58

页数：22

共 131 条

[1] THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN
BARGMANN, CI
HUNG, MC
WEINBERG, RA
[J]. NATURE, 1986, 319 (6050) : 226 - 230
[2] BODNER SM, 1992, ONCOGENE, V7, P743
[3] BOS JL, 1989, CANCER RES, V49, P4682
[4] BULZEBRUCK H, 1992, CANCER-AM CANCER SOC, V70, P1102, DOI 10.1002/1097-0142(19920901)70:5<1102::AID-CNCR2820700514>3.0.CO
[5] 2-5
[6] P53 IMMUNOSTAINING POSITIVITY IS ASSOCIATED WITH REDUCED SURVIVAL AND IS IMPERFECTLY CORRELATED WITH GENE-MUTATIONS IN RESECTED NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF LCSG-871
CARBONE, DP
MITSUDOMI, T
CHIBA, I
PIANTADOSI, S
RUSCH, V
NOWAK, JA
MCINTIRE, D
SLAMON, D
GAZDAR, A
MINNA, J
[J]. CHEST, 1994, 106 (06) : S377 - S381
[7] IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE IN CLINICAL ONCOLOGY
CHANG, FJ
SYRJANEN, S
SYRJANEN, K
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 1009 - 1022
[8] CHIBA I, 1990, ONCOGENE, V5, P1603
[9] CIBAS ES, 1989, CANCER, V63, P1552, DOI 10.1002/1097-0142(19890415)63:8<1552::AID-CNCR2820630817>3.0.CO
[10] 2-F